Using CancerGRACE.org
Create a Profile
Create a profile on GRACE. Your dashboard lets you save information that is important to you, and allows you to join the conversation! Click the 'My Account' link to return to your dashboard at any time.
Featured Content

En este foro anual de pacientes en vivo, los principales oncólogos torácicos de todo el mundo discuten temas relevantes para los objetivos del cáncer de pulmón, así como mutaciones raras. En esta serie de videos los Doctores Fernando Diaz, Luis Raez, Luis Corrales, Estelamari Rodriguez y Alberto Chiappori presentan el Panel de Discusión donde hablan sobre temas relevantes del cáncer de pulmón. Click aquí para ver la playlist completa.
The board and staff at the Global Resource for Advancing Cancer Education (GRACE) are very pleased to announce the appointment of Nancy Iler Sladicka, Ph.D. as President of the Board of Directors effective November 3, 2023. In this role, Nancy will guide the strategic priorities of the organization and preside over the Board meetings, working closely with Amy Bickleman, Executive Director, and Matt Tan, Vice President. Nancy brings over 25 years of experience in healthcare communications...

En este foro anual de pacientes en vivo, los principales oncólogos torácicos de todo el mundo discuten temas relevantes para los objetivos del cáncer de pulmón, así como mutaciones raras. En esta serie de videos los Doctores Fernando Diaz, Luis Raez, Luis Corrales, Estelamari Rodriguez y Alberto Chiappori presentan el Panel de Discusión donde hablan sobre temas relevantes del cáncer de pulmón. Click aquí para ver la playlist completa.

This series includes videos from the breakout sessions presented by Dr. Stephen Liu, including the following topics: Safety and Toxicity of Selpercatinib Versus Pralsetinib The Future of RET+ NSCLC Treatment NTRK+ NSCLC: Treatment Options and Side Effects NRG1 Fusions: Treatment Options To watch the complete playlist click here .

The September 2023 Blood Cancer OncTalk has now ended. Videos are available OnDemand! The full unedited versions of the September 2023 Blood Cancer OncTalk, are now available OnDemand. These topics will be edited and offered as shorter videos in the coming weeks. The full videos are available on our YouTube channel via this link: https://youtube.com/playlist?list=PLWsyUmdjLXhG4km7yALHmLjQSeUQg-36x ALL Available Slides are found under 'Documents Available for Download' on the left sidebar of the...

This series includes videos from the breakout sessions presented by Dr. Stephen Liu and Dr. Misako Nagasaka, including the following topics: Treatments and Study Data for Patients with ALK+ NSCLC Treatment Options & Study Data for Patients with ROS1+ NSCLC Rare Fusions in NSCLC: RET RET Fusion Treatment: Selpercatinib RET Fusion Treatment: Pralsetinib To watch the complete playlist click here .

This next series of videos from the Q&A sessions includes the following videos: Q&A: What Are the Platform Options for SBRT? Why Some Patients Remain on TKIs Without Acquiring Resistance? High PD-L1:Wait for Genetic Testing Results Before Treatment? To watch the complete playlist click here .
Forum Discussions
Hi Stan, It's good to hear your voice and know your cheesecakes are still making the rounds. Though I'm sure startling, I imagine some of those little pockets of the house...
Hi Rutbats, Welcome to GRACE and thanks for the kind words.
We can't say what you should or shouldn't do and I can't say why your RA doc made their...
Thank you very much for your quick answer, Janine.
I have an appointment with a pulmonologist in 10 days. I will summarize the conversation with him here, so that other people...
Glad to know you're moving forward with a pulmonologist. The more you know the better the conversation with your pulmonologist. Remember you can help your docs know what level their conversation...
Hi Terry, Welcome to Grace.
I saw this exact post somewhere else months back and the only response was to a lab. I hope that doesn't happen here, we don't allow...
Stan - Thank you once again for your kind words. Thank you as well for your donation. As you know, your donation helps us to exist and continue to fulfill our...